Case-finding and genetic testing for familial hypercholesterolaemia in primary care
N Qureshi, RK Akyea, B Dutton, SE Humphries… - Heart, 2021 - heart.bmj.com
Objective Familial hypercholesterolaemia (FH) is a common inherited disorder that remains
mostly undetected in the general population. Through FH case-finding and direct access to …
mostly undetected in the general population. Through FH case-finding and direct access to …
Women's experiences of heavy menstrual bleeding and medical treatment: A qualitative study in primary care
B Dutton, J Kai - British Journal of General Practice, 2023 - bjgp.org
Background Heavy menstrual bleeding (HMB) is common and can affect women’s lives.
Evidence on women’s experiences and their treatment of this problem after seeking primary …
Evidence on women’s experiences and their treatment of this problem after seeking primary …
[HTML][HTML] Improving primary care identification of familial breast cancer risk using proactive invitation and decision support
Family history of breast cancer is a key risk factor, accounting for up to 10% of cancers. We
evaluated the proactive assessment of familial breast cancer (FBC) risk in primary care. …
evaluated the proactive assessment of familial breast cancer (FBC) risk in primary care. …
Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
N Qureshi, RK Akyea, B Dutton, J Leonardi-Bee… - Open …, 2021 - openheart.bmj.com
Objective Familial hypercholesterolaemia (FH) is a common inherited disorder causing
premature coronary heart disease (CHD) and death. We have developed the novel Familial …
premature coronary heart disease (CHD) and death. We have developed the novel Familial …
Medical treatment for heavy menstrual bleeding in primary care: 10-year data from the ECLIPSE trial
J Kai, B Dutton, Y Vinogradova, N Hilken… - British Journal of …, 2022 - bjgp.org
Background Heavy menstrual bleeding (HMB) is a common problem that can significantly
affect women’s lives. There is a lack of evidence on long-term outcomes after seeking …
affect women’s lives. There is a lack of evidence on long-term outcomes after seeking …
[HTML][HTML] Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study.
J Kai, B Dutton, Y Vinogradova, N Hilken… - Health Technology …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Heavy menstrual bleeding is a common problem that can significantly affect
women's lives until menopause. There is a lack of evidence on longer-term outcomes after …
women's lives until menopause. There is a lack of evidence on longer-term outcomes after …
[HTML][HTML] Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD
JF Mosley, LL Smith, BN Dutton - Pharmacy and Therapeutics, 2016 - ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD), a relatively common respiratory disorder in
the US, is the third leading cause of death in this country. 1 It has been estimated that 15 …
the US, is the third leading cause of death in this country. 1 It has been estimated that 15 …
Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review
This systematic review evaluated the effectiveness of strategies to identify and manage
patients with familial risk of breast, ovarian, colorectal and prostate cancer in primary care to …
patients with familial risk of breast, ovarian, colorectal and prostate cancer in primary care to …
Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience
Background Familial hypercholesterolaemia (FH) is a common inherited condition causing
elevated cholesterol, premature heart disease, and early death. Although FH can be …
elevated cholesterol, premature heart disease, and early death. Although FH can be …
[HTML][HTML] qualitative study
J Kai, B Dutton, Y Vinogradova, N Hilken… - Rates of medical or …, 2023 - ncbi.nlm.nih.gov
Objectives As noted in Chapter 1, most evidence on the treatment of HMB has focused on
the effectiveness of medical treatments or surgery in reducing menstrual blood loss, 9 and …
the effectiveness of medical treatments or surgery in reducing menstrual blood loss, 9 and …